Vijayalakshmi Venkatesan
Overview
Explore the profile of Vijayalakshmi Venkatesan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sivapalan S, Dharmalingam S, Ashokkumar V, Venkatesan V, Angappan M
J Ethnopharmacol
. 2023 Oct;
319(Pt 3):117314.
PMID: 37832812
Ethnopharmacological Relevance: Herbal medicines derived from plant extraction are affordable, more therapeutically effective, and have fewer side effects than contemporary medications. Vitex negundo L. (V. negundo). is a medicinal shrub,...
2.
Sampath S, Venkatesan V, Ghosh S, Kotikalapudi N
Curr Obes Rep
. 2023 Aug;
12(3):308-331.
PMID: 37578613
Purpose Of Review: Metabolic syndrome (MetS), also called the 'deadly quartet' comprising obesity, diabetes, dyslipidemia, and hypertension, has been ascertained to have a causal role in the pathogenesis of osteoarthritis...
3.
Sivapalan S, Dharmalingam S, Venkatesan V, Angappan M, Ashokkumar V
J Ethnopharmacol
. 2022 Nov;
303:115963.
PMID: 36442758
Ethnopharmacological Relevance: Herbal remedies can be used to treat a variety of chronic inflammatory illnesses, like rheumatoid arthritis and leprosy. The plant Calotropis gigantea (C. gigantea) belongs to the family...
4.
Kotikalapudi N, Sampath S, Sinha S, R B, Mungamuri S, Venkatesan V
Cell Tissue Res
. 2022 Oct;
391(1):127-144.
PMID: 36227376
Obesity (Ob) depicts a state of energy imbalance(s) being characterized by the accumulation of excessive fat and which predisposes to several metabolic diseases. Mesenchymal stem cells (MSCs) represent a promising...
5.
Singh H, Venkatesan V
Curr Diabetes Rev
. 2022 May;
19(3):e250522205241.
PMID: 35619270
Diabetes (Type 1 and Type 2) is the most burdensome condition for the healthcare systems worldwide. Continuous glucose monitoring (CGM) is a powerful tool in the management of diabetes that...
6.
Kotikalapudi N, Sampath S, Sinha S, Bhonde R, Mungamuri S, Venkatesan V
Hum Cell
. 2022 Jan;
35(2):557-571.
PMID: 35091972
Obesity poses a significant risk factor for the onset of metabolic syndrome with allied complications, wherein mesenchymal stem cell therapy is seen as a promising treatment for obesity-induced metabolic syndrome....
7.
Kotikalapudi N, Sampath S, Sukesh Narayan S, R B, Nemani H, Mungamuri S, et al.
Sci Rep
. 2021 Sep;
11(1):19627.
PMID: 34584190
No abstract available.
8.
Sampath S, Rath S, Kotikalapudi N, Venkatesan V
Inflammopharmacology
. 2021 Sep;
29(6):1701-1717.
PMID: 34546477
Osteoarthritis (OA) is the most prevalent joint disease predominantly characterized by inflammation which drives cartilage destruction. Mesenchymal stem cells-condition medium (MSC-CM) or the secretome is enriched with bioactive factors and...
9.
Kotikalapudi N, Sampath S, Sukesh Narayan S, R B, Nemani H, Mungamuri S, et al.
Sci Rep
. 2021 Aug;
11(1):16983.
PMID: 34417511
Obesity (Ob) poses a significant risk factor for the onset of metabolic syndrome with associated complications, wherein the Mesenchymal Stem Cell (MSC) therapy shows pre-clinical success. Here, we explore the...
10.
Sampath S, Kotikalapudi N, Venkatesan V
Stem Cell Investig
. 2021 Apr;
8:5.
PMID: 33829057
Mesenchymal stem cells (MSCs) have gained wide therapeutic acceptance in regenerative medicine due to their potential in repair process in restoring the damaged tissues and controlling inflammation. In the present...